TABLE 1.
Species | Serotype | Strain or variant | Presence of characteristic |
Reference | |||
---|---|---|---|---|---|---|---|
Capsule | Pili | Opc | Opa | ||||
N. meningitidis | A | C751; Opa− | − | − | − | − | 43 |
A | C751; Opa+ | − | − | − | OpaD | 43 | |
B | H44/76 | − | + | − | − | 36; current study | |
B | H44/76 | − | + | − | OpaJ | 36; current study | |
E. coli | NA | PC2984 | NA | NA | NA | NA | 10 |
NA | PC2984 | NA | NA | NA | OpaJ | 10 | |
NA | PC2984 | NA | NA | NA | OpaB | 10 | |
N. gonorrhoeae | P9-1 | NA | − | NA | − | 22, 41 | |
P9-13 | NA | − | NA | Opaa | 22, 41 |
NA, not applicable. Note that other than the results presented in Fig. 6, all studies used derivatives of N. meningitidis strain C751 and/or N. gonorrhoeae strain P9.